Jennifer L. Faulkner
Research Associate III
University of Arkansas for Medical Sciences
postdoc
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Jennifer L. Faulkner's research focuses on the development and evaluation of therapeutic vaccines and immunotherapies for various cancers and human papillomavirus (HPV)-related conditions. Her work includes investigating the efficacy of peptide-based therapeutic vaccines, such as PepCan, in treating cervical intraepithelial neoplasia (CIN2/3) and reducing head and neck cancer recurrence. Faulkner also studies peripheral immune correlates of tumor response in breast cancer patients receiving experimental vaccines like P10s-PADRE. Additionally, her research has explored the use of automated alerts in electronic health records to encourage genetic counseling and testing for patients at high risk for hereditary cancer syndromes.
Faulkner has published 14 research articles, accumulating 351 citations and an h-index of 8. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including David W. Ussery, Jasmine Crane, Nadia Darwish, and Teresa Evans, with whom she shares multiple publications. Her recent work extends to 2026, indicating ongoing activity in her research areas.
Metrics
- h-index: 8
- Publications: 14
- Citations: 351
Selected Publications
- A Randomized Double-Blind Placebo-Controlled Phase I/II Clinical Trial of a Human Papillomavirus Therapeutic Vaccine, PepCan, for Reducing Head and Neck Cancer Recurrence (2026) DOI
- A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025) DOI
- Abstract 3860: Characterizing peripheral immune correlates of tumor response in breast cancer patients immunized with the P10s-PADRE vaccine (2024) DOI
- A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023) DOI
- Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes? (2022) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics